Home > R&D > Introduction
Daewoong��s R&D Centers strive to develop innovative drugs that can improve global health.
Our R&D centers have a mission to improve its global drug development system and R&D pipeline to realize the vision of ��providing better health for people through its total dedication to healthcare��
- Nabota
- USA/Europe/China & Line Ext, etc.
- Process Innovation for Global production
- EGF/hGH/BMP-2/EPO
- Skin Care - Cosmetics for GF Wound healing
- Hyaluronic acid/Cholic acid Development
- NCEs
-
Antiulcer, Autoimmune disease, Fibrotic disease, NASH,
Neuropathic pain, Diabetes - FDC & IMD Drug
- Diabetes, Hypertension/Hyperlipidema etc.
- New platform technology
- Depot, Nano, Patch, Inhalation device etc.
Platform
Therapeutic Area
